Approval · Notice of Compliance 17313 · 2015
P.G. 600: Notice of Compliance 17313
Issued September 24, 2015
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 17313
- Date
- September 24, 2015
- Company
- Intervet Canada CorpKirkland, Quebec, Canada
- Product type
- Veterinary
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Manufacturing change
- Therapeutic class
- Gonadotrophines
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| P.G. 600 | 00803472 | Marketed |
Medicinal ingredients
- GONADOTROPHIN SERUM (PMSG) 400 UNIT per VIAL
- CHORIONIC GONADOTROPIN 200 UNIT per VIAL